Prof. Dr. Friedemann Paul
NeuroCure Clinical Research Center
Charité Campus Mitte
Tel: +49 (0)30 450 539 705
Fax: +49 (0)30 450 539 915
Experimental and Clinical Research Center
Lindenberger Weg 80
We are working on this with a translational approach; this means that we try to transfer new developments and findings from basic research directly into clinical work.
The Clinical Neuroimmunology Group is one of four working groups at the(NCRC).
Here you can find theconcerning our latest results.
Prof. Dr. med. Friedemann Paul, Facharzt für Neurologie
Dr. med. Judith Bellmann-Strobl, Consultant Neurologist
Head of the Study Ambulance of the Research Group
Dr. med. Susanna Asseyer, Physician
Dr. med. Marcus D'Souza, Physician
Dr. med. Joseph Kuchling, Physician
PD Dr. Tanja Schmitz-Hübsch, Consultant Neurologist
Dr. med. Nadja Siebert, Consultant Neurologist
Dr. med. Alexander Brandt, Physician
Head of the Neuro Diagnostic Laboratory
Lina Samira Bahr, M.Sc. Ernährungswissenschaftlerin
Charlotte Bereuter, Optometritian
Claudia Chien, PhD Student Medical Neuroscience
Priscilla Koduah-Bäcker, PhD Student Medical Neurosciences
Seydamirhosein Motamedi, M.Sc. PhD Student
Svenja Specovius, M.Sc. PhD Student
Hanna Zimmermann, M.Eng.PhD Student
Cynthia Kraut, Medical Technician, Radiology/ Data and Image Analysis
Claudia Messelhäuße, Study Assistant
Mirjana Mitrovic, Assistant
Susan Pikol, Medical Technician/ Data and Image Analysis
Bibiane Seeger-Schwinge, Medical Technician
Gritt Stoffels, Study Assistant, MS Nurse
Katharina Stößlein, Study Assistant
Bettina Zwingenberger, Study Assistant
Frederike Cosima Oertel
PD Dr. med. Jan-Markus Dörr, MD (Neurologie, Klinik Hennigsdorf), Consultant Neurologist
Sebastian Mansow-Model, Mathematician (Motognosis, Berlin)
Karen Otte, Information Scientist (Motognosis, Berlin)
Dr. med. Jens Würfel, MD (MIAC AG, Basel, CH), Consultant Radiology
Dr. med. Athina Papadopoulou, Consultant Neurologist
MS is causally based upon autoimmune processes; this means that the body's own immune system mistakes the nervous system as "foreign" and initiates an inflammation reaction, as a result of which nerve cells and axons, with their sheathing protective coating, are damaged. Many different neurological symptoms can occur. People suffering from MS can for example feel tingling sensations or numbness, receive paralyses or balance disorders, stumble more frequently or develop problems with their sight.
The course taken by MS varies greatly between individuals, and its course cannot be predicted well in individual patients. One of our fields of activity is the development and establishing of new progress and prognosis markers. These include, for example, the improvement of possibilities in the field of magnetic resonance imaging (MRI), e.g. ultra-high-field MRI and also the establishing of new imaging procedures such as optical coherence tomography (OCT).
It is not yet possible to cure MS. Progression and symptoms can, however, be positively influenced by various drug therapies and non-drug measures. Another fields of activity is the development and conducting of clinical studies with the aim of improving the therapeutic possibilities of MS. These include on the one hand clinical studies of phases I to IV, which we partly carry out in cooperation with the industry, and on the other hand new non-drug treatment approaches such as repetitive transcranial magnetic stimulation for the treatment of depressiveness and fatigue and visual restitution therapy for the improvement of persisting sight impairments after inflammation of the optic nerve.
Other diseases on which we have a research focus are Susac syndrome and neuromyelitis optica.
The Clinical Neuroimmunology group works in close cooperation with the interdisciplinary outpatient clinics of the Experimental and Clinical Research Center (ECRC ). In addition to the, other additional disciplines ensure state-of-the-art patient care based on the current state of knowledge.